[
  {
    "ts": null,
    "headline": "Stryker Launches T2 Alpha Humerus Nailing System for Fracture Care",
    "summary": "SYK launches the T2 Alpha Humerus Nailing System to enhance complex fracture care, boosting procedural efficiency and strengthening its trauma portfolio.",
    "url": "https://finnhub.io/api/news?id=3d983df41a8a4aaeff96dbfd4bb79af2799ac72e0b5ff685019345f78f5fd390",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770919020,
      "headline": "Stryker Launches T2 Alpha Humerus Nailing System for Fracture Care",
      "id": 139073211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "SYK launches the T2 Alpha Humerus Nailing System to enhance complex fracture care, boosting procedural efficiency and strengthening its trauma portfolio.",
      "url": "https://finnhub.io/api/news?id=3d983df41a8a4aaeff96dbfd4bb79af2799ac72e0b5ff685019345f78f5fd390"
    }
  },
  {
    "ts": null,
    "headline": "Are Wall Street Analysts Bullish on Stryker Stock?",
    "summary": "Stryker has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=77e54f1ae4f64e69d6f46f75e45b1c4b243222e005e4d3cfafde8eef0bb51711",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770902839,
      "headline": "Are Wall Street Analysts Bullish on Stryker Stock?",
      "id": 139067011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=77e54f1ae4f64e69d6f46f75e45b1c4b243222e005e4d3cfafde8eef0bb51711"
    }
  },
  {
    "ts": null,
    "headline": "Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth",
    "summary": "Enovis management has guided for up to low-double-digit Recon growth in 2026. Learn more about ENOV stock and why I maintain my buy rating.",
    "url": "https://finnhub.io/api/news?id=a71b4c31a8b5266cceef44469d713f7cb38fd321663d3e12213912cc1d4768b4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770876000,
      "headline": "Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth",
      "id": 139054286,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2170576115/image_2170576115.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Enovis management has guided for up to low-double-digit Recon growth in 2026. Learn more about ENOV stock and why I maintain my buy rating.",
      "url": "https://finnhub.io/api/news?id=a71b4c31a8b5266cceef44469d713f7cb38fd321663d3e12213912cc1d4768b4"
    }
  }
]